Answers are grounded in this paper and cite their sources.
Demonstrates the formation and reactivity of heterobimetallic complexes in CO2 reduction, indicating potential for efficient catalysts.
We describe the selective formation of heterobimetallic complexes, exploiting the coordination trends of the developed bis-terpyridyl trans -1,2-cyclohexadiamine platform ( L ). Following a stepwise addition, we first reacted ligand L toward tetrakisacetonitrile transition metal precursors, [M(MeCN) 4 ][BF 4 ] 2 (where M = Fe or Ni), to generate the monometallic complexes 1 ([FeL][BF 4 ] 2 ) and 2 ([NiL][BF 4 ] 2 ). These species were later combined with the tetrakisacetonitrile precursor [Cu(MeCN) 4 ][BF 4 ], generating the corresponding heterobimetallic complexes 3 ([FeCuL(MeCN) 2 ][BF 4 ] 3 ) and 4 ([NiCuL(MeCN) 2 ][BF 4 ] 3 ). The four species obtained, in high yields, have been structurally characterized. Their cyclic voltammetry analysis revealed the impact of the Cu I -atom presence on the heterobimetallic complexes under argon and carbon dioxide (CO 2 ) atmospheres. Controlled potential electrolysis studies revealed the instability of complexes 1 – 4 toward CO2RR, generating the heterogeneous material in solution and on the electrode surface. In contrast, CO 2 photoreduction studies revealed higher stability and photocatalytic activity for the Fe II -based complexes ( 1 and 3 ), generating CO with 88% selectivity.
No takes yet. Share an insight, caveat, or question.
Peralta-Arriaga et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: